26.4 C
New York
Saturday, June 13, 2026

Tag: pharmaceutical

newssourceFORcompanyinformationcontent1marketreleases

HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support

Horsewood supplement evaluated: 7-herb botanical male vitality formula, NCCIH research context, and 60-day money-back guarantee.

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

CALGARY, Alberta, June 12, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that the Company has elected to voluntarily delist its common shares from the TSX Venture Exchange (“TSXV”). The Company will provide additional information on timing for the completion of the delisting of its common shares in a separate press release.

Marco Pharma International appears on the Enterprise Podcast Network

Director of Operations Isaac Conyers IV discusses the company's practitioner-focused model and 35-year historyROSEBURG, Ore., June 12, 2026 /PRNewswire/ -- Marco Pharma International, a...

BRC Therapeutics Appoints Ron Eastman to Board of Directors

Veteran Pharma Executive and Healthcare Investor Brings More Than 40 Years of Drug Development, Operations and Investment ExperienceMONTEREY, Calif., June 12, 2026 /PRNewswire/ -- BRC...

Sustainable Pharmaceutical Packaging Market to reach USD 270.4 billion by 2031, Wissen Research

SHERIDAN, Wyo., June 12, 2026 /PRNewswire/ -- According to a new study by Wissen Research, the global sustainable pharmaceutical packaging market is projected to...

In Vitro Toxicology Testing Market worth $20.97 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the In Vitro Toxicology Testing Market is projected to grow from about USD...

In Vitro Toxicology Testing Market worth $20.97 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the In Vitro Toxicology Testing Market is projected to grow from about USD...

$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

Beijing China-Germany Forum for Industrial Cooperation and Development — China-Germany (China-Europe) Hidden Champions Forum 2026 Held

BEIJING, June 12, 2026 (GLOBE NEWSWIRE) -- On May 25, the Beijing China-Germany Forum for Industrial Cooperation and Development -- China-Germany (China-Europe) Hidden Champions Forum 2026 commenced at the China-Germany International Conference and Exhibition Center in Shunyi District, Beijing. Themed "Joint Innovation • Integrated Development", the forum is co-hosted by the Shunyi District People's Government and the European Senate of Economy, and jointly initiated by the International Cooperation Center (ICC) of the National Development and Reform Commission (NDRC), among others. The forum brought together over 400 Chinese and international participants, including nearly 100 political and business figures, as well as heads of Hidden Champion enterprises from Germany and other parts of Europe.

The Galien Foundation Honours Leaders in Life Sciences Innovation with the 2026 Prix Galien UK Awards

-- Winners across biotechnology, digital health, medical technology, pharmaceuticals, public sector, and health equity categories honoured at prestigious Awards Ceremony LONDON, June 12, 2026...

Evaxion receives Prix Galien UK Award for Best digital health solution

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology™.

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab...

Folding IBC Market to Reach USD 5.2 Billion by 2035 as Returnable Packaging Solutions and Logistics Optimization Drive Global Demand

NEWARK, Del., June 11, 2026 /PRNewswire/ -- The global folding IBC market is witnessing remarkable growth as industries increasingly adopt returnable bulk packaging solutions to...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceutical

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers